Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

PRCT

Procept BioRobotics Corp

Feb 10 • 04:00PM ET

29.95

+0.74 2.53 %

Healthcare • Medical Devices • USA • NASD

Peers: ISRG MDT ABT SYK BSX EW COO ZBH TFX PODD

| Held by: VTI VB IWM VBK VXF BOTZ IWO VTWO SCHA IHI

Index	RUT	P/E	-	EPS (ttm)	-1.54	Insider Own	3.70%	Shs Outstand	55.87M	Perf Week	2.60%
Market Cap	1.67B	Forward P/E	-	EPS next Y	-1.14	Insider Trans	0.98%	Shs Float	53.81M	Perf Month	-8.77%
Enterprise Value	1.46B	PEG	-	EPS next Q	-0.32	Inst Own	104.36%	Short Float	13.36%	Perf Quarter	-6.17%
Income	-84.58M	P/S	5.58	EPS this Y	13.67%	Inst Trans	-1.18%	Short Ratio	5.59	Perf Half Y	-22.75%
Sales	299.91M	P/B	4.40	EPS next Y	24.46%	ROA	-19.10%	Short Interest	7.19M	Perf YTD	-4.80%
Book/sh	6.81	P/C	5.69	EPS next 5Y	29.42%	ROE	-27.22%	52W High	70.80 -57.70%	Perf Year	-57.06%
Cash/sh	5.27	P/FCF	-	EPS past 3/5Y	-8.57% -12.56%	ROIC	-18.51%	52W Low	26.66 12.36%	Perf 3Y	-18.86%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	86.74% 105.21%	Gross Margin	63.48%	Volatility	7.24% 5.60%	Perf 5Y	-
Dividend TTM	-	EV/Sales	4.86	EPS Y/Y TTM	21.22%	Oper. Margin	-30.85%	ATR (14)	1.67	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.19	Sales Y/Y TTM	50.07%	Profit Margin	-28.20%	RSI (14)	48.31	Recom	1.43
Dividend Gr. 3/5Y	- -	Current Ratio	8.43	EPS Q/Q	4.74%	SMA20	0.67%	Beta	0.98	Target Price	52.75
Payout	-	Debt/Eq	0.21	Sales Q/Q	42.76%	SMA50	-6.22%	Rel Volume	0.80	Prev Close	29.21
Employees	756	LT Debt/Eq	0.20	Earnings	Feb 24 AMC	SMA200	-29.29%	Avg Volume	1.29M	Price	29.95
IPO	Sep 15, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.88% 3.08%	Trades		Volume	1,029,531	Change	2.53%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-12-25	Initiated	UBS	Buy	$62
Dec-08-25	Downgrade	BofA Securities	Buy → Neutral	$38
Sep-02-25	Upgrade	Oppenheimer	Perform → Outperform	$60
Jul-09-25	Initiated	Stephens	Overweight	$70
Jul-07-25	Initiated	Oppenheimer	Perform
Dec-02-24	Initiated	Morgan Stanley	Overweight	$105
Nov-14-24	Initiated	Jefferies	Hold	$95
Aug-11-23	Initiated	Piper Sandler	Overweight	$42
May-31-23	Initiated	William Blair	Outperform
Oct-31-22	Initiated	BTIG Research	Neutral
Oct-25-22	Initiated	Truist	Buy	$58
Sep-02-22	Initiated	Wells Fargo	Overweight	$49
Jul-15-22	Initiated	KeyBanc Capital Markets	Overweight	$47
Jun-23-22	Initiated	B. Riley Securities	Buy	$53
Oct-11-21	Initiated	SVB Leerink	Outperform	$46
Oct-11-21	Initiated	Guggenheim	Buy	$45
Oct-11-21	Initiated	Goldman	Neutral	$37
Oct-11-21	Initiated	Cowen	Outperform	$50
Oct-11-21	Initiated	BofA Securities	Buy	$48

Show Previous Ratings

Feb-05-26 08:15AM	IQVIA Holdings (IQV) Q4 Earnings and Revenues Top Estimates (Zacks) -5.29%
Feb-04-26 05:40PM	Steris (STE) Meets Q3 Earnings Estimates (Zacks)
04:03PM	PROCEPT BioRobotics to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference (GlobeNewswire)
Jan-26-26 04:03PM	PROCEPT BioRobotics to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City (GlobeNewswire)
Jan-08-26 09:12AM	Truist Maintains Buy Rating on Procept BioRobotics (PRCT) Amid MedTech Sector Rotation (Insider Monkey)
08:41AM	Loading…
Jan-07-26 08:41AM	ISRG Trading 4% Below All-Time High: Should You Buy the Stock Now? (Zacks)
Dec-22-25 06:50AM	Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) (Insider Monkey) +6.86%
Dec-15-25 07:03AM	3 Underrated Robotics Stocks Poised for Huge Gains (MarketBeat)
Nov-20-25 04:03PM	PROCEPT BioRobotics to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025 (GlobeNewswire) +7.06%
Nov-18-25 05:07AM	Piper Sandler Reiterates a Buy on PROCEPT BioRobotics Corporation (PRCT) (Insider Monkey)
Nov-05-25 12:04AM	PROCEPT BioRobotics Corp (PRCT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com) -9.74%
Nov-04-25 05:40PM	PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:03PM	PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance (GlobeNewswire)
Oct-30-25 10:00AM	Mettler-Toledo (MTD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-29-25 09:00AM	2 Robotics Stocks Riding the Sensor and Medical Boom (Motley Fool)
10:00AM	Loading…
Oct-28-25 10:00AM	Earnings Preview: PROCEPT BioRobotics Corporation (PRCT) Q3 Earnings Expected to Decline (Zacks)
Oct-20-25 11:08PM	Truist Lowers PT on PROCEPT BioRobotics Corporation (PRCT) to $50 From $64, Keeps a Buy Rating (Insider Monkey) +5.31%
09:20AM	Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval (Zacks)
Oct-15-25 04:03PM	PROCEPT BioRobotics to Report Third Quarter 2025 Financial Results on November 4, 2025 (GlobeNewswire)
Sep-15-25 09:01AM	ISRG Stock Down More than 13% in 3 Months: How to Play the Stock? (Zacks)
Sep-04-25 06:13AM	Your Move, Human: Analysts See Growth Potential in These 2 Robotics Stocks (TipRanks)
Aug-27-25 08:29AM	SP Platform's 88% Procedure Growth: The Next Frontier for ISRG? (Zacks)
Aug-21-25 12:30PM	Wall Street short sellers have been crushed in 2025. Better days might be coming. (MarketWatch)
11:15AM	PROCEPT BioRobotics (PRCT) Outlook Adjusted as System Replacement Forecasts Shift (Insider Monkey)
Aug-13-25 12:08PM	Leerink Partners Reiterates a Buy Rating on PROCEPT BioRobotics (PRCT) (Insider Monkey)
Aug-06-25 05:45PM	PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -5.05% -13.35%
04:03PM	PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance (GlobeNewswire)
Aug-05-25 08:15AM	AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates (Zacks)
Aug-04-25 05:45PM	Si-Bone (SIBN) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Jul-31-25 10:30AM	Envoy Medical, Inc. (COCH) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -5.53%
10:00AM	Loading…
Jul-30-25 10:00AM	Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jul-25-25 07:00AM	Edwards loses longtime TAVR leader Larry Wood (MedTech Dive)
Jul-24-25 06:00PM	PROCEPT BioRobotics President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO (GlobeNewswire)
Jul-23-25 08:00AM	Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation Therapy (GlobeNewswire)
Jul-21-25 04:03PM	PROCEPT BioRobotics to Report Second Quarter 2025 Financial Results on August 6, 2025 (GlobeNewswire)
Jul-14-25 09:15PM	Aquablation Therapy's Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule (GlobeNewswire)
Apr-29-25 04:03PM	PROCEPT BioRobotics to Attend Four Upcoming Investor Conferences in May & June (GlobeNewswire)
Apr-24-25 04:03PM	PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops (GlobeNewswire) -5.64%
02:37PM	PROCEPT BioRobotics Corporation (PRCT) Q1 2025 Earnings Call Transcript (Seeking Alpha)
08:15AM	PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM	PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance (GlobeNewswire)
Apr-10-25 04:03PM	PROCEPT BioRobotics Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas (GlobeNewswire) -7.22%
Mar-29-25 06:03PM	PROCEPT BioRobotics (PRCT): One of the Best Robotics Stocks to Buy According to Billionaires (Insider Monkey)
Mar-24-25 08:00AM	WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation Therapy to Laser Enucleation (GlobeNewswire)
Mar-20-25 09:05AM	Invesco Health Care Fund Q4 2024 Commentary (SeekingAlpha)
Mar-14-25 08:00AM	PROCEPT BioRobotics Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada (GlobeNewswire)
Feb-26-25 09:32AM	Q4 2024 Procept Biorobotics Corp Earnings Call (Thomson Reuters StreetEvents) +8.61%
02:15AM	PROCEPT BioRobotics Corp (PRCT) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
Feb-25-25 05:25PM	PROCEPT BioRobotics Corporation (PRCT) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:02PM	PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results (GlobeNewswire)
01:22AM	PROCEPT BioRobotics Corp (PRCT) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Feb-13-25 02:10PM	Procept BioRobotics Corp. (PRCT): Among the Best Mid-Cap Growth Stocks to Buy According to Analysts (Insider Monkey)
Feb-07-25 08:00AM	PROCEPT BioRobotics to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference (GlobeNewswire)
Jan-16-25 12:00PM	PROCEPT BioRobotics (PRCT) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Dec-28-24 04:59AM	Morgan Stanley Sees Potential Growth in These 2 Surgical Robotic Stocks (TipRanks)
Nov-29-24 11:15AM	PROCEPT BioRobotics Corporation (PRCT) Gains 40% Following Strong Q3 Earnings and Upgraded Guidance (Insider Monkey)
Nov-26-24 04:05PM	PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024 (GlobeNewswire)
Nov-07-24 12:00PM	Are You Looking for a Top Momentum Pick? Why PROCEPT BioRobotics Corporation (PRCT) is a Great Choice (Zacks)
Nov-01-24 02:27PM	These IBD 50 Leaders Melt Gains As Stock Market Wavers (Investor's Business Daily)
Oct-29-24 08:43PM	PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock (GlobeNewswire) +6.25%
12:00PM	All You Need to Know About PROCEPT BioRobotics (PRCT) Rating Upgrade to Strong Buy (Zacks)
11:56AM	Medical Gear Stock Surges Past Buy Point On Upbeat Sales Outlook (Investor's Business Daily)
03:03AM	PROCEPT BioRobotics Corp (PRCT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
Oct-28-24 05:41PM	Procept BioRobotics, A Top 5% Stock, Makes A Bullish Move On Quarterly Beat And Raise (Investor's Business Daily) +32.33%
04:19PM	PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock (GlobeNewswire)
02:17PM	Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential (Benzinga)
11:39AM	PROCEPT BioRobotics Jumps 30% Today on Massive Revenue Surge (GuruFocus.com)
08:10AM	PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:00AM	PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance (GlobeNewswire)
07:00AM	Deborah Kilpatrick Joins Sonder Capital as its Newest Venture Partner (PR Newswire)
Oct-25-24 09:35AM	Down -15.71% in 4 Weeks, Here's Why PROCEPT BioRobotics (PRCT) Looks Ripe for a Turnaround (Zacks)
09:01AM	Earnings To Watch: PROCEPT BioRobotics Corp (PRCT) Reports Q3 2024 Result (GuruFocus.com)
Oct-21-24 10:00AM	PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-09-24 04:04PM	PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024 (GlobeNewswire)
Oct-08-24 12:29PM	PROCEPT BioRobotics wins FDA IDE for aquablation trial in prostate cancer (Medical Device Network) +6.29%
Oct-07-24 04:04PM	PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer (GlobeNewswire)
Oct-05-24 06:04PM	PROCEPT BioRobotics Corporation (PRCT) Advances Urology with AI-Integrated HYDROS Robotic System; Price Target Raised to $99 (Insider Monkey)
Sep-25-24 09:01AM	Is Procept Biorobotics Corp. (PRCT) the Worst AI Stock to Buy? (Insider Monkey)
Sep-23-24 09:03AM	Procept Biorobotics Corporation (PRCT): Why Are Short Sellers Betting Against This Hospital Tech Innovator? (Insider Monkey) -5.60%
Aug-30-24 05:57AM	Do You Believe in the Growth Prospects of PROCEPT BioRobotics (PRCT)? (Insider Monkey)
Aug-28-24 04:03PM	PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024 (GlobeNewswire)
Aug-22-24 01:05PM	PROCEPT BioRobotics' (PRCT) HYDROS System Gets FDA Clearance (Zacks)
09:12AM	PROCEPT (PRCT) Grows in Urology With FDA Clearance for HYDROS (Zacks)
Aug-21-24 07:00AM	PROCEPT BioRobotics Announces FDA Clearance of the HYDROS Robotic System, the Next-Generation, AI-Powered Platform for Aquablation Therapy (GlobeNewswire) +28.36%
Aug-14-24 04:30PM	3 Robotics Stocks to Sell in August Before They Crash & Burn (InvestorPlace)
Aug-01-24 05:50PM	PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -7.45%
04:03PM	PROCEPT BioRobotics Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance (GlobeNewswire)
Jul-15-24 04:03PM	PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024 (GlobeNewswire)
Jun-27-24 04:38PM	You've Been Warned! 3 Robotics Stocks to Buy Now or Regret Forever. (InvestorPlace)
Jun-19-24 02:40AM	Insider Selling: EVP, CLO, Corporate Secretary Alaleh Nouri Sells Shares of PROCEPT BioRobotics ... (GuruFocus.com)
Jun-17-24 04:03PM	PROCEPT BioRobotics Announces New CPT Category I Code from the American Medical Association for Aquablation therapy (GlobeNewswire)
Jun-03-24 04:03PM	PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024 (GlobeNewswire)
May-17-24 05:20PM	Intuitive Surgical, IBD Stock Of The Day, Feels Its Way Toward Buy Point (Investor's Business Daily)
May-14-24 06:00AM	From Science Fiction to Reality: 3 Robotics Stocks for Automatic Riches (InvestorPlace)
May-13-24 04:05PM	PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference (GlobeNewswire)
May-06-24 09:40AM	Piper Sandler Adjusts Price Target on PROCEPT BioRobotics to $75 From $67, Maintains Overweight Rating (MT Newswires)
08:00AM	Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia (GlobeNewswire)
03:08AM	Procept BioRobotics Insider Sold Shares Worth $1,200,000, According to a Recent SEC Filing (MT Newswires)
May-04-24 02:58AM	Director Thomas Krummel Sells 20,000 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
May-03-24 04:00PM	PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2024 Earnings Call Transcript (Insider Monkey)

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Desai Antal Rohit	Director	Aug 14 '25	Option Exercise	1.33	26,749	35,576	35,152	Aug 15 04:53 PM
MOLL FREDERIC H	Director	Aug 13 '25	Buy	39.26	20,000	785,138	863,159	Aug 14 04:18 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Aug 14 '25	Option Exercise	4.52	11,000	49,720	72,473	Aug 14 04:15 PM
Desai Antal Rohit	Director	Jun 10 '25	Sale	63.91	25,000	1,597,711	64,363	Jun 12 07:28 PM
Desai Antal Rohit	Director	Jun 11 '25	Sale	63.38	25,000	1,584,525	39,363	Jun 12 07:28 PM
Desai Antal Rohit	Director	Jun 12 '25	Sale	61.49	25,000	1,537,256	14,363	Jun 12 07:28 PM
SHAM SHIBLAQ	Officer	Jun 06 '25	Proposed Sale	64.13	20,000	1,282,638		Jun 06 04:22 PM
Shiblaq Hisham	EVP, Chief Comm. Officer	Jun 06 '25	Option Exercise	5.18	20,000	103,600	83,133	Jun 06 04:02 PM
Shiblaq Hisham	EVP, Chief Comm. Officer	Jun 06 '25	Sale	64.13	20,000	1,282,637	63,133	Jun 06 04:02 PM
Desai Antal Rohit	Director	Jun 05 '25	Sale	64.79	25,000	1,619,830	89,363	Jun 05 08:05 PM
Desai Antal Rohit	Director	Jun 04 '25	Sale	61.02	25,000	1,525,556	114,363	Jun 05 08:05 PM
Desai Antal Rohit	Director	Jun 03 '25	Sale	60.66	25,000	1,516,475	139,363	Jun 05 08:05 PM
222 DNA TRUST	Director	Jun 03 '25	Proposed Sale	57.94	150,000	8,691,000		Jun 03 04:24 PM
Zadno Reza	President, CEO	May 09 '25	Option Exercise	7.27	13,759	100,028	186,829	May 13 04:59 PM
Zadno Reza	President, CEO	Mar 18 '25	Sale	57.06	5,475	312,404	173,070	Mar 19 04:16 PM
Waters Kevin	EVP, CFO	Mar 18 '25	Sale	57.06	733	41,825	107,991	Mar 19 04:15 PM
Shiblaq Hisham	EVP, Chief Comm. Officer	Mar 18 '25	Sale	57.06	247	14,094	63,133	Mar 19 04:08 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Mar 18 '25	Sale	57.06	316	18,031	61,473	Mar 19 04:04 PM
Zadno Reza	Officer	Mar 18 '25	Proposed Sale	57.06	5,475	312,404		Mar 18 07:20 PM
Waters Kevin	Officer	Mar 18 '25	Proposed Sale	57.06	733	41,825		Mar 18 07:07 PM
Shiblaq Hisham	Officer	Mar 18 '25	Proposed Sale	57.06	247	14,094		Mar 18 04:24 PM
Nouri Alaleh	Officer	Mar 18 '25	Proposed Sale	57.06	316	18,031		Mar 18 04:03 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Mar 06 '25	Sale	61.31	3,641	223,230	61,789	Mar 10 04:31 PM
Shiblaq Hisham	EVP, Chief Comm. Officer	Mar 06 '25	Sale	61.31	3,588	219,980	63,380	Mar 10 04:29 PM
Waters Kevin	EVP, CFO	Mar 06 '25	Sale	61.31	3,662	224,517	108,724	Mar 10 04:28 PM
Zadno Reza	President, CEO	Mar 06 '25	Sale	61.31	15,916	975,810	178,545	Mar 10 04:26 PM
Zadno Reza	Officer	Mar 06 '25	Proposed Sale	61.31	15,916	975,735		Mar 06 06:42 PM
Waters Kevin	Officer	Mar 06 '25	Proposed Sale	61.31	3,662	224,500		Mar 06 06:32 PM
Shiblaq Hisham	Officer	Mar 06 '25	Proposed Sale	61.31	3,588	219,963		Mar 06 06:02 PM
Nouri Alaleh	Officer	Mar 06 '25	Proposed Sale	61.31	3,641	223,212		Mar 06 05:49 PM

Open in Screener

EW

Edwards Lifesciences Corp

Feb 10 • 04:00PM ET

77.05

+0.25 0.33 %

Healthcare • Medical Devices • USA • NYSE

EW Edwards Lifesciences Corp daily Stock Chart

Peers: MDT ABT BSX SYK ISRG ZBH TFX COO ALGN

| Held by: VTI VOO VO IVV SPY VTV VOT XLV IHI VHT

Index	S&P 500	P/E	41.59	EPS (ttm)	1.85	Insider Own	1.37%	Shs Outstand	580.30M	Perf Week	-6.15%
Market Cap	44.71B	Forward P/E	23.43	EPS next Y	3.29	Insider Trans	-1.24%	Shs Float	572.37M	Perf Month	-9.49%
Enterprise Value	42.31B	PEG	1.76	EPS next Q	0.72	Inst Own	87.36%	Short Float	1.41%	Perf Quarter	-7.60%
Income	1.09B	P/S	7.37	EPS this Y	15.02%	Inst Trans	-1.62%	Short Ratio	2.23	Perf Half Y	-1.42%
Sales	6.07B	P/B	4.38	EPS next Y	11.68%	ROA	10.23%	Short Interest	8.09M	Perf YTD	-9.62%
Book/sh	17.57	P/C	14.90	EPS next 5Y	13.31%	ROE	13.59%	52W High	87.89 -12.33%	Perf Year	8.37%
Cash/sh	5.17	P/FCF	55.60	EPS past 3/5Y	-9.12% 7.03%	ROIC	9.99%	52W Low	65.94 16.85%	Perf 3Y	-0.19%
Dividend Est.	-	EV/EBITDA	24.06	Sales past 3/5Y	4.08% 6.70%	Gross Margin	79.71%	Volatility	2.76% 2.45%	Perf 5Y	-10.81%
Dividend TTM	-	EV/Sales	6.97	EPS Y/Y TTM	65.58%	Oper. Margin	26.75%	ATR (14)	1.94	Perf 10Y	192.60%
Dividend Ex-Date	-	Quick Ratio	3.29	Sales Y/Y TTM	6.00%	Profit Margin	17.92%	RSI (14)	30.78	Recom	1.74
Dividend Gr. 3/5Y	- -	Current Ratio	4.00	EPS Q/Q	-75.99%	SMA20	-6.05%	Beta	0.94	Target Price	97.79
Payout	0.00%	Debt/Eq	0.06	Sales Q/Q	13.26%	SMA50	-8.12%	Rel Volume	1.82	Prev Close	76.80
Employees	15800	LT Debt/Eq	0.06	Earnings	Feb 10 AMC	SMA200	-3.15%	Avg Volume	3.63M	Price	77.05
IPO	Mar 27, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	-6.36% 1.48%	Trades		Volume	6,561,748	Change	0.33%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-09-26	Upgrade	TD Cowen	Hold → Buy	$97
Dec-18-25	Upgrade	JP Morgan	Neutral → Overweight	$100
Nov-03-25	Upgrade	Raymond James	Mkt Perform → Outperform	$96
Oct-29-25	Upgrade	Wolfe Research	Underperform → Peer Perform
Oct-29-25	Upgrade	Jefferies	Hold → Buy	$98
Oct-08-25	Downgrade	Oppenheimer	Outperform → Perform
Oct-07-25	Upgrade	Evercore ISI	In-line → Outperform	$88
Jul-29-25	Upgrade	BTIG Research	Neutral → Buy	$100
Apr-24-25	Upgrade	Piper Sandler	Neutral → Overweight	$80
Jan-30-25	Upgrade	Stifel	Hold → Buy	$75 → $90
Jan-16-25	Downgrade	Wolfe Research	Peer Perform → Underperform	$60
Dec-16-24	Upgrade	BofA Securities	Neutral → Buy
Oct-11-24	Resumed	Morgan Stanley	Equal-Weight	$70
Sep-18-24	Downgrade	Jefferies	Buy → Hold	$85 → $70
Jul-31-24	Upgrade	Daiwa Securities	Neutral → Outperform
Jul-29-24	Upgrade	Wolfe Research	Underperform → Peer Perform
Jul-25-24	Downgrade	Truist	Buy → Hold	$110 → $82
Jul-25-24	Downgrade	TD Cowen	Buy → Hold	$100 → $70
Jul-25-24	Downgrade	Robert W. Baird	Outperform → Neutral	$102 → $70
Jul-25-24	Downgrade	JP Morgan	Overweight → Neutral	$105 → $72

Show Previous Ratings

Today 07:44AM	Edwards reports strong 2025 despite Q4 EPS miss (Medical Device Network)
01:24AM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
12:01AM	Edwards Lifesciences Corp (EW) Q4 2025 Earnings Call Highlights: Strong Sales Growth Amidst ... (GuruFocus.com)
Feb-10-26 10:07PM	Edwards Lifesciences Q4 Earnings Call Highlights (MarketBeat)
06:00PM	Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics (Zacks)
04:46PM	Loading…
04:46PM	Edwards Lifesciences Pops On Its Bullish 2026 View Despite Mixed Fourth Quarter (Investor's Business Daily)
04:29PM	Edwards Lifesciences Comes Up Mixed, But Offers A Bullish 2026 View (Investor's Business Daily)
04:15PM	Edwards Lifesciences Reports Fourth Quarter Results (Business Wire)
Feb-09-26 02:08PM	MedTech Stocks to Report Earnings on Feb. 10: DGX, ZBH & EW (Zacks)
09:47AM	What Are Wall Street Analysts' Target Price for Edwards Lifesciences Stock? (Barchart)
Feb-06-26 08:15AM	The TAVR Pioneer Bets Everything on One Market as Its Competitor Spreads Risk (24/7 Wall St.)
Feb-05-26 09:15AM	Ahead of Edwards Lifesciences (EW) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Feb-04-26 10:23AM	Edwards Lifesciences' Q4 Earnings on Deck: Here's What to Expect (Zacks)
Feb-03-26 07:05AM	Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026 (Business Wire)
Feb-02-26 09:51PM	Edwards Lifesciences Corporation (EW): A Bull Case Theory (Insider Monkey)
07:05AM	Loading…
07:05AM	Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference (Business Wire)
Jan-31-26 09:35AM	Analyst Upgrades Signal Renewed Growth Cycle for Edwards Lifesciences Corporation (EW) (Insider Monkey)
Jan-30-26 02:31PM	Renewed Growth Cycle Drives a Favorable Sentiment Towards Edwards Lifesciences (EW) (Insider Monkey)
Jan-26-26 05:06AM	Intuitives cardiac initiative includes valve repair, LAA closure (MedTech Dive)
Jan-25-26 11:44AM	Beyond Biotech-3 Healthcare Stocks for Growth-Minded Investors (MarketBeat)
Jan-19-26 09:25AM	Does Edwards Lifesciences (EW) Have Strong Double-Digit Earnings Potential? (Insider Monkey)
Jan-15-26 08:42AM	Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy (Benzinga)
Jan-14-26 01:19PM	JPM26: Edwards Lifesciences targets 10% growth in 2026 (Medical Device Network)
07:50AM	Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now? (Zacks)
Jan-13-26 09:01AM	What to Expect From Edwards Lifesciences' Q4 2025 Earnings Report (Barchart)
Jan-12-26 09:31AM	Court Ruling Ends Edwards Lifesciences $1.2 Billion Plan To Acquire JenaValve (Benzinga)
07:38AM	Edwards JenaValve acquisition nixed as FTC injunction approved by court (Medical Device Network)
05:37AM	Edwards calls off JenaValve buyout after court halts deal (MedTech Dive)
Jan-09-26 06:48PM	Edwards Comments on JenaValve Acquisition (Business Wire)
Dec-26-25 12:20PM	EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy (Zacks)
12:45PM	Loading…
Dec-24-25 12:45PM	HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
08:40AM	How Well Is Boston Scientific Placed for Long-Term Endoscopy Growth? (Zacks)
Dec-23-25 10:21AM	The Zacks Analyst Blog Highlights Cardinal Health, Medtronic, Intuitive Surgical and Edwards Lifesciences (Zacks)
09:00AM	FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy (Business Wire)
Dec-22-25 11:07AM	4 Large-Cap MedTech Stocks to Keep Winning Streaks Alive in 2026 (Zacks)
Dec-18-25 07:05AM	Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-11-25 08:09AM	Should You Continue to Hold EW Stock in Your Portfolio? (Zacks)
Dec-04-25 09:00AM	Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference (Business Wire)
Dec-03-25 12:45PM	Cooper Companies to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
Dec-02-25 03:57AM	How Is Edwards Lifesciences Stock Performance Compared to Other Medical Device Stocks? (Barchart)
Nov-30-25 03:29PM	HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
Nov-24-25 08:25AM	BSX vs. EW: Which Heart Device Stock Is the Smarter Investment Now? (Zacks)
Nov-11-25 05:58AM	Edwards Lifesciences Stock: Is Wall Street Bullish or Bearish? (Barchart)
Nov-09-25 04:00PM	Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease (Business Wire)
Nov-07-25 01:23PM	Top Analyst Reports for JPMorgan Chase, Salesforce & Arista Networks (Zacks)
Nov-05-25 01:59PM	Do Options Traders Know Something About Edwards Lifesciences Stock We Don't? (Zacks)
10:27AM	Is the Options Market Predicting a Spike in Edwards Lifesciences Stock? (Zacks)
Oct-31-25 07:35PM	Closing Bell Movers: Amazon soars to all-time highs on earnings (TipRanks)
04:25PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
04:12PM	The 'Halo Effect' Bolstering Edwards Lifesciences' Biggest Moneymaker (Investor's Business Daily)
11:59AM	Edwards CFO Scott Ullem to exit post (MedTech Dive)
10:51AM	Demographic Megatrend: Stocks Poised to Benefit From Global Aging (Zacks)
10:17AM	EW Stock Gains on Q3 Earnings and Revenue Beat, Margins Crash (Zacks)
07:56AM	Edwards boosts FY25 outlook after Q3 surpasses expectations (Medical Device Network)
Oct-30-25 11:05PM	Edwards Lifesciences Corp (EW) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
06:00PM	Edwards Lifesciences (EW) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:24PM	Edwards Jumps On Beat-And-Raise, Announces CFO Transition (Investor's Business Daily)
04:15PM	Edwards Lifesciences Announces CFO Transition Plan (Business Wire)
04:13PM	Edwards Lifesciences Reports Third Quarter Results (Business Wire)
Oct-29-25 09:35AM	Skyworks upgraded, UnitedHealth downgraded: Wall Street's top analyst calls (The Fly)
Oct-28-25 09:37AM	Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
09:15AM	Exploring Analyst Estimates for Edwards Lifesciences (EW) Q3 Earnings, Beyond Revenue and EPS (Zacks)
Oct-27-25 03:06PM	Successful Patient Outcomes Demonstrated With Edwards' SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025 (Business Wire) +6.20%
02:22PM	Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025 (Business Wire)
10:00AM	Idexx Laboratories (IDXX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-24-25 09:00AM	Will SYK's Q3 Results Reflect MedSurg Strength & Rebound in Orthopaedics? (Zacks)
Oct-23-25 07:53AM	Will RVTY Q3 Earnings Reflect Segmental Strength Amid Rising Demand? (Zacks)
07:05AM	Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025 (Business Wire)
Oct-21-25 06:33AM	Piper Sandler Maintains Overweight on Edwards Lifesciences (EW) Ahead of PARTNER 3 7-Year Results (Insider Monkey)
Oct-17-25 09:08AM	WST Q3 Earnings Preview: Can GLP-1 Momentum Outweigh Margin Pressure? (Zacks)
08:26AM	Robust TAVR Growth to Drive Edwards Lifesciences' Q3 Earnings (Zacks)
Oct-13-25 08:14AM	Pulse Biosciences Unveils Promising First-in-Human Data for nPulse (Zacks)
Oct-10-25 08:44AM	Abbott to Report Q3 Earnings: Medical Devices Arm in Focus (Zacks)
Oct-08-25 11:16AM	TLRY Gears Up to Report Q1 Earnings: Cannabis Recovery in Focus (Zacks)
09:45AM	Intel, FedEx downgraded: Wall Street's top analyst calls (The Fly)
Oct-07-25 09:50AM	Netflix upgraded, Dollar Tree downgraded: Wall Street's top analyst calls (The Fly)
Oct-06-25 07:58AM	Here's What to Expect From Edwards Lifesciences Next Earnings Report (Barchart)
Oct-02-25 07:10AM	AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Sep-19-25 04:02PM	Edwards Lifesciences Corporation (EW): A Bull Case Theory (Insider Monkey)
Sep-10-25 04:52AM	Edwards Lifesciences Corporation (EW) Welcomes Newly Updated ESC/EACTS Guidelines for Severe Aortic Stenosis (AS) (Insider Monkey)
Sep-09-25 11:44AM	Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings (Motley Fool)
Sep-05-25 12:21PM	Edwards Lifesciences TAVR growth continues as global demand rises (Medical Device Network)
Sep-04-25 04:29PM	Top Stock Reports for Apple, Novartis & Charles Schwab (Zacks)
Sep-03-25 05:55AM	Edwards, Medtronic and Abbott stand to benefit from new TAVR guidelines in Europe (MedTech Dive)
Sep-02-25 11:13AM	Leerink Partners Lifts Edwards Lifesciences (EW) Price Target Amid Buybacks Focus (Insider Monkey)
06:51AM	Edwards Lifesciences Stock: Is EW Outperforming the Healthcare Sector? (Barchart)
Sep-01-25 12:20PM	3 Healthcare Pathbreakers With Long-Term Tailwinds (MarketBeat)
11:51AM	ESC 2025: Structural heart disease guidelines updated following Edwards trial results (Medical Device Network)
Aug-29-25 09:48AM	ABT vs. EW: Which Structural Heart Device Stock Is Worth Buying Now? (Zacks)
09:09AM	Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care (Business Wire)
Aug-21-25 02:10PM	Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating (Investor's Business Daily)
Aug-19-25 04:15PM	Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase (Business Wire)
Aug-15-25 05:57AM	FTC to block Edwards Lifesciences acquisition of JenaValve due to competitive concerns (Medical Device Network)
Aug-14-25 08:33AM	Abbott Taps Growing TMVR Market With Tendyne System (Zacks)
Aug-13-25 01:41PM	Edwards Lifesciences Stock: Analyst Estimates & Ratings (Barchart)
Aug-11-25 03:56PM	Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings (Motley Fool)
Aug-08-25 02:00PM	Pediatrix Medical's Q2 Earnings Beat on Strong Patient Volumes (Zacks)
Aug-07-25 07:26AM	FTC files lawsuit to halt Edwards acquisition of JenaValve (Medical Device Network)
Aug-06-25 02:44PM	FTC Files Lawsuit to Block Edwards Lifesciences' Purchase of JenaValve Technology (The Wall Street Journal)
02:17PM	JenaValve Responds to FTCs Action Against Proposed Edwards Lifesciences Acquisition (GlobeNewswire)

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lippis Daniel J.	CVP, TAVR	Jan 09 '26	Option Exercise	59.26	1,019	60,383	23,021	Jan 09 05:41 PM
Lippis Daniel J.	CVP, TAVR	Jan 09 '26	Sale	85.70	1,019	87,332	22,002	Jan 09 05:41 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 06 '26	Option Exercise	59.26	11,340	671,971	43,210	Jan 06 06:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 06 '26	Sale	85.66	11,340	971,429	31,870	Jan 06 06:02 PM
BOBO DONALD E JR	Officer	Jan 06 '26	Proposed Sale	85.66	45,360	3,885,715		Jan 06 04:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 12 '25	Sale	83.76	11,386	953,748	38,970	Dec 12 05:57 PM
Lippis Daniel J.	CVP, JAPAC	Dec 12 '25	Option Exercise	59.26	1,019	60,383	23,021	Dec 12 05:57 PM
Lippis Daniel J.	CVP, JAPAC	Dec 12 '25	Sale	84.03	1,019	85,625	22,002	Dec 12 05:57 PM
STONE HEISZ LESLIE	Director	Dec 12 '25	Sale	83.41	2,615	218,120	30,948	Dec 12 05:57 PM
BOBO JR FAMILY TRUST	Officer	Dec 12 '25	Proposed Sale	83.74	5,900	494,066		Dec 12 04:22 PM
STONE HEISZ LESLIE	Director	Dec 12 '25	Proposed Sale	83.41	2,615	218,119		Dec 12 04:04 PM
BOBO DONALD E JR	Officer	Dec 12 '25	Proposed Sale	83.78	5,487	459,682		Dec 12 04:03 PM
Chopra Daveen	CVP, TMTT & Surgical	Dec 11 '25	Sale	84.38	2,000	168,750	32,201	Dec 11 05:58 PM
Chopra Daveen	Officer	Dec 11 '25	Proposed Sale	84.38	2,000	168,750		Dec 11 04:01 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 10 '25	Option Exercise	59.26	11,340	671,971	61,696	Dec 10 06:58 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 10 '25	Sale	83.83	11,340	950,581	50,356	Dec 10 06:58 PM
Zovighian Bernard J	CEO	Dec 08 '25	Option Exercise	59.26	25,350	1,502,157	106,326	Dec 10 06:58 PM
Zovighian Bernard J	CEO	Dec 08 '25	Sale	85.21	21,487	1,831,006	84,839	Dec 10 06:58 PM
Zovighian Bernard J	CEO	Dec 10 '25	Sale	83.45	3,863	322,367	8,597	Dec 10 06:58 PM
BOBO DONALD E JR	Officer	Dec 10 '25	Proposed Sale	83.83	11,340	950,582		Dec 10 04:38 PM
Zovighian Bernard J	Officer	Dec 10 '25	Proposed Sale	83.45	3,863	322,367		Dec 10 04:37 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 09 '25	Option Exercise	59.26	7,700	456,277	47,598	Dec 09 05:01 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 09 '25	Sale	84.47	7,700	650,412	39,898	Dec 09 05:01 PM
Markowitz Wayne	CVP, JAPAC	Dec 08 '25	Sale	86.01	583	50,144	17,563	Dec 08 05:50 PM
Markowitz Wayne	Officer	Dec 08 '25	Proposed Sale	86.01	583	50,144		Dec 08 04:13 PM
Zovighian Bernard J	Officer	Dec 08 '25	Proposed Sale	85.21	21,487	1,831,006		Dec 08 04:12 PM
Wood Larry L	Former Affiliate	Nov 11 '25	Proposed Sale	85.12	26,850	2,285,355		Nov 12 01:30 PM
Ullem Scott B.	CVP, Chief Financial Officer	Nov 10 '25	Option Exercise	59.26	13,000	770,337	52,898	Nov 10 06:07 PM
Ullem Scott B.	CVP, Chief Financial Officer	Nov 10 '25	Sale	83.08	13,000	1,080,093	39,898	Nov 10 06:07 PM
Lippis Daniel J.	CVP, JAPAC	Nov 10 '25	Option Exercise	59.26	1,020	60,442	23,022	Nov 10 06:06 PM
Lippis Daniel J.	CVP, JAPAC	Nov 10 '25	Sale	82.55	1,020	84,196	22,002	Nov 10 06:06 PM
Lippis Daniel J.	Officer	Nov 10 '25	Proposed Sale	82.55	3,058	252,423		Nov 10 04:08 PM
Ullem Scott B.	Officer	Nov 10 '25	Proposed Sale	83.08	20,700	1,719,841		Nov 10 04:07 PM
Wood Larry L	Former Affiliate	Oct 16 '25	Proposed Sale	73.02	8,950	653,522		Oct 16 04:07 PM
Chopra Daveen	CVP, TMTT	Aug 25 '25	Sale	81.95	2,500	204,865	30,996	Aug 25 06:25 PM
Chopra Daveen	Officer	Aug 25 '25	Proposed Sale	81.95	2,500	204,865		Aug 25 04:15 PM
Wood Larry L	Global President TAVR & Surg	Aug 18 '25	Option Exercise	59.26	8,950	530,347	215,850	Aug 18 06:11 PM
Wood Larry L	Global President TAVR & Surg	Aug 18 '25	Sale	78.06	8,950	698,679	206,900	Aug 18 06:11 PM
Wood Larry L	Officer	Aug 18 '25	Proposed Sale	78.06	8,950	698,679		Aug 18 04:29 PM
Lippis Daniel J.	CVP, JAPAC	Jul 28 '25	Sale	79.46	4,114	326,900	22,002	Jul 28 06:23 PM
Lippis Daniel J.	Officer	Jul 28 '25	Proposed Sale	79.46	4,114	326,900		Jul 28 04:04 PM
Wood Larry L	Global President TAVR & Surg	Jun 16 '25	Option Exercise	59.26	8,950	530,347	215,850	Jun 16 05:09 PM
Wood Larry L	Global President TAVR & Surg	Jun 16 '25	Sale	75.23	8,950	673,268	206,900	Jun 16 05:09 PM
Wood Larry L	Officer	Jun 16 '25	Proposed Sale	75.23	8,950	673,268		Jun 16 04:20 PM
Zovighian Bernard J	CEO	May 30 '25	Sale	77.21	16,099	1,243,065	9,564	Jun 03 05:15 PM
Zovighian Bernard J	CEO	Jun 03 '25	Sale	77.32	967	74,772	8,597	Jun 03 05:15 PM
Zovighian Bernard J	Officer	Jun 03 '25	Proposed Sale	77.32	967	74,772		Jun 03 04:29 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jun 02 '25	Sale	77.40	2,570	198,911	50,356	Jun 02 05:01 PM
BOBO DONALD E JR	Officer	Jun 02 '25	Proposed Sale	77.40	2,570	198,911		Jun 02 04:03 PM
Zovighian Bernard J	Officer	May 30 '25	Proposed Sale	77.21	16,099	1,243,064		May 30 04:31 PM
Chopra Daveen	CVP, TMTT	May 22 '25	Sale	75.08	1,500	112,612	33,496	May 22 05:08 PM
Chopra Daveen	Officer	May 22 '25	Proposed Sale	75.07	1,500	112,612		May 22 04:01 PM
Lippis Daniel J.	CVP, JAPAC	May 09 '25	Option Exercise	45.28	330	14,941	26,946	May 09 07:35 PM
Lippis Daniel J.	CVP, JAPAC	May 09 '25	Sale	74.42	330	24,560	26,616	May 09 07:35 PM
Markowitz Wayne	GM & SVP, Surgical	May 07 '25	Sale	75.08	268	20,121	9,299	May 09 07:34 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 09 '25	Option Exercise	45.28	11,250	509,363	52,348	May 09 07:34 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 09 '25	Sale	74.40	11,250	837,035	41,098	May 09 07:34 PM
Lippis Daniel J.	Officer	May 09 '25	Proposed Sale	74.42	330	24,560		May 09 04:00 PM
Markowitz Wayne	Officer	May 07 '25	Proposed Sale	75.08	268	20,121		May 07 04:48 PM
Zovighian Bernard J	CEO	May 05 '25	Option Exercise	45.28	7,462	337,855	65,746	May 06 05:13 PM
Zovighian Bernard J	CEO	May 05 '25	Sale	74.91	5,980	447,977	58,284	May 06 05:13 PM
Zovighian Bernard J	Officer	May 05 '25	Proposed Sale	74.91	5,980	447,977		May 05 04:03 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 14 '25	Option Exercise	45.28	9,500	430,129	56,706	Apr 14 06:18 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 14 '25	Sale	69.81	9,500	663,196	47,206	Apr 14 06:18 PM
Lippis Daniel J.	CVP, JAPAC	Apr 08 '25	Option Exercise	45.28	300	13,583	23,163	Apr 08 05:12 PM
Lippis Daniel J.	CVP, JAPAC	Apr 08 '25	Sale	70.61	300	21,183	22,863	Apr 08 05:12 PM
Lippis Daniel J.	Officer	Apr 08 '25	Proposed Sale	70.61	300	21,183		Apr 08 04:19 PM
Ullem Scott B.	CVP, Chief Financial Officer	Mar 26 '25	Option Exercise	45.28	11,250	509,363	41,637	Mar 26 04:45 PM
Ullem Scott B.	CVP, Chief Financial Officer	Mar 26 '25	Sale	70.87	11,250	797,267	30,387	Mar 26 04:45 PM
Ullem Scott B.	Officer	Mar 26 '25	Proposed Sale	70.87	22,500	1,594,534		Mar 26 04:14 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '25	Option Exercise	45.28	9,500	430,129	56,436	Mar 13 05:41 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '25	Sale	67.96	9,500	645,624	46,936	Mar 13 05:41 PM
Zovighian Bernard J	CEO	Mar 10 '25	Option Exercise	45.28	7,463	337,900	66,546	Mar 10 07:35 PM
Zovighian Bernard J	CEO	Mar 10 '25	Sale	69.51	6,164	428,448	59,083	Mar 10 07:35 PM
Lippis Daniel J.	CVP, JAPAC	Mar 10 '25	Option Exercise	45.28	400	18,111	22,988	Mar 10 07:34 PM
Lippis Daniel J.	CVP, JAPAC	Mar 10 '25	Sale	69.48	400	27,792	22,588	Mar 10 07:34 PM
Zovighian Bernard J	Officer	Mar 10 '25	Proposed Sale	69.51	6,164	428,448		Mar 10 04:13 PM
Lippis Daniel J.	Officer	Mar 10 '25	Proposed Sale	69.48	400	27,792		Mar 10 04:13 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 28 '25	Option Exercise	45.28	11,250	509,363	41,637	Feb 28 05:05 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 28 '25	Sale	70.78	11,250	796,327	30,387	Feb 28 05:05 PM
LORANGER STEVEN R	Director	Feb 14 '25	Option Exercise	45.32	5,739	260,073	66,111	Feb 14 04:41 PM
LORANGER STEVEN R	Director	Feb 14 '25	Sale	76.42	5,739	438,576	60,372	Feb 14 04:41 PM
LORANGER STEVEN R	Director	Feb 14 '25	Proposed Sale	76.42	5,739	438,576		Feb 14 04:11 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 13 '25	Option Exercise	45.28	11,250	509,363	41,811	Feb 13 06:04 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 13 '25	Sale	75.76	11,250	852,272	30,561	Feb 13 06:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '25	Option Exercise	45.28	6,500	294,299	53,436	Feb 13 06:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '25	Sale	75.75	6,500	492,363	46,936	Feb 13 06:04 PM
Lippis Daniel J.	CVP, JAPAC	Feb 13 '25	Option Exercise	45.28	500	22,638	23,689	Feb 13 06:04 PM
Lippis Daniel J.	CVP, JAPAC	Feb 13 '25	Sale	76.34	500	38,170	23,189	Feb 13 06:04 PM
STONE HEISZ LESLIE	Director	Feb 13 '25	Option Exercise	45.32	5,739	260,073	35,774	Feb 13 06:04 PM
STONE HEISZ LESLIE	Director	Feb 13 '25	Sale	75.86	5,739	435,371	30,035	Feb 13 06:04 PM
Lippis Daniel J.	Officer	Feb 13 '25	Proposed Sale	76.34	500	38,170		Feb 13 04:05 PM
STONE HEISZ LESLIE	Director	Feb 13 '25	Proposed Sale	75.86	5,739	435,371		Feb 13 04:04 PM
BOBO DONALD E JR	Officer	Feb 13 '25	Proposed Sale	75.75	25,500	1,931,579		Feb 13 04:03 PM

PRCT

Procept BioRobotics Corp

EW

Edwards Lifesciences Corp

Upgrade your FINVIZ experience